112 related articles for article (PubMed ID: 3411443)
1. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
Uozumi J; Litterst CL
J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
[TBL] [Abstract][Full Text] [Related]
2. The effect of cisplatin on renal ATPase activity in vivo and in vitro.
Uozumi J; Litterst CL
Cancer Chemother Pharmacol; 1985; 15(2):93-6. PubMed ID: 2990752
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
Mason RW; Hogg SJ; Edwards IR
Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
[TBL] [Abstract][Full Text] [Related]
4. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
5. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
Valentovic MA; Scott LA; Madan E; Yokel RA
Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412
[TBL] [Abstract][Full Text] [Related]
6. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
7. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats.
Appenroth D; Winnefeld K; Schröter H; Rost M
J Appl Toxicol; 1993; 13(3):189-92. PubMed ID: 8326088
[TBL] [Abstract][Full Text] [Related]
9. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
Cacini W; Harden EA; Skau KA
Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
Hanigan MH; Gallagher BC; Taylor PT
Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
Uozumi J; Litterst CL
Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
Guo JH
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
[TBL] [Abstract][Full Text] [Related]
14. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
Jones MM; Basinger MA; Mitchell WM; Bradley CA
Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
[TBL] [Abstract][Full Text] [Related]
16. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
Koikawa Y
Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.
Hanada K; Ninomiya K; Ogata H
J Pharm Pharmacol; 2000 Nov; 52(11):1345-53. PubMed ID: 11186242
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
Najjar TA; Saad SY
Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
[TBL] [Abstract][Full Text] [Related]
19. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
Jones MM; Basinger MA; Beaty JA; Holscher MA
Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
[TBL] [Abstract][Full Text] [Related]
20. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
Nagai N; Ogata H
Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
